US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US9556175B2
(en)
|
2002-08-21 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
|
US10202383B2
(en)
|
2002-08-21 |
2019-02-12 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US9321791B2
(en)
|
2002-08-21 |
2016-04-26 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US8119648B2
(en)
|
2002-08-21 |
2012-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US9108964B2
(en)
|
2002-08-21 |
2015-08-18 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US8178541B2
(en)
|
2002-08-21 |
2012-05-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US8664232B2
(en)
|
2002-08-21 |
2014-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US10023574B2
(en)
|
2002-08-21 |
2018-07-17 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
US7838529B2
(en)
|
2002-08-22 |
2010-11-23 |
Boehringer Ingelheim International Gmbh |
Xanthine derivates, their preparation and their use in pharmaceutical compositions
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7696212B2
(en)
|
2002-11-08 |
2010-04-13 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7560450B2
(en)
|
2002-11-21 |
2009-07-14 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US8034941B2
(en)
|
2003-06-18 |
2011-10-11 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7550455B2
(en)
|
2003-11-27 |
2009-06-23 |
Boehringer Ingelheim International Gmbh |
8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
US8697868B2
(en)
|
2004-02-18 |
2014-04-15 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
US7645763B2
(en)
|
2004-02-23 |
2010-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
US7432262B2
(en)
|
2004-03-13 |
2008-10-07 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
US7667035B2
(en)
|
2004-05-10 |
2010-02-23 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
US7470716B2
(en)
|
2004-06-24 |
2008-12-30 |
Boehringer Ingelheim International Gmbh |
Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
|
US7906539B2
(en)
|
2004-06-24 |
2011-03-15 |
Boehringer Ingelheim International Gmbh |
Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
|
US7495003B2
(en)
|
2004-09-11 |
2009-02-24 |
Boehringer Ingelheim International Gmbh |
8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7495002B2
(en)
|
2004-09-14 |
2009-02-24 |
Boehringer Ingelheim International Gmbh |
3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7820815B2
(en)
|
2004-11-05 |
2010-10-26 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines
|
US8541450B2
(en)
|
2004-11-05 |
2013-09-24 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
|
US9751855B2
(en)
|
2004-11-05 |
2017-09-05 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
|
US9499546B2
(en)
|
2004-11-05 |
2016-11-22 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
|
US8883805B2
(en)
|
2004-11-05 |
2014-11-11 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
|
US8637530B2
(en)
|
2005-07-30 |
2014-01-28 |
Boehringer Ingelheim International Gmbh |
8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
|
US8106060B2
(en)
|
2005-07-30 |
2012-01-31 |
Boehringer Ingelheim International Gmbh |
8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
|
US9493462B2
(en)
|
2006-05-04 |
2016-11-15 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US11084819B2
(en)
|
2006-05-04 |
2021-08-10 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US9815837B2
(en)
|
2006-05-04 |
2017-11-14 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US11919903B2
(en)
|
2006-05-04 |
2024-03-05 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US8232281B2
(en)
|
2006-05-04 |
2012-07-31 |
Boehringer Ingelheim International Gmbh |
Uses of DPP-IV inhibitors
|
US10080754B2
(en)
|
2006-05-04 |
2018-09-25 |
Boehringer Ingelheim International Gmbh |
Uses of DPP IV inhibitors
|
US9173859B2
(en)
|
2006-05-04 |
2015-11-03 |
Boehringer Ingelheim International Gmbh |
Uses of DPP IV inhibitors
|
US8673927B2
(en)
|
2006-05-04 |
2014-03-18 |
Boehringer Ingelheim International Gmbh |
Uses of DPP-IV inhibitors
|
US10301313B2
(en)
|
2006-05-04 |
2019-05-28 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US9266888B2
(en)
|
2006-05-04 |
2016-02-23 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
US11033552B2
(en)
|
2006-05-04 |
2021-06-15 |
Boehringer Ingelheim International Gmbh |
DPP IV inhibitor formulations
|
US11291668B2
(en)
|
2006-05-04 |
2022-04-05 |
Boehringer Ingelheim International Gmbh |
Uses of DPP IV inhibitors
|
US8071583B2
(en)
|
2006-08-08 |
2011-12-06 |
Boehringer Ingelheim International Gmbh |
Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus
|
US10022379B2
(en)
|
2008-04-03 |
2018-07-17 |
Boehringer Ingelheim International Gmbh |
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
|
US10973827B2
(en)
|
2008-04-03 |
2021-04-13 |
Boehringer Ingelheim International Gmbh |
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
|
US9155705B2
(en)
|
2008-04-03 |
2015-10-13 |
Boehringer Ingelheim International Gmbh |
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
|
US9415016B2
(en)
|
2008-04-03 |
2016-08-16 |
Boehringer Ingelheim International Gmbh |
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
|
US8853156B2
(en)
|
2008-08-06 |
2014-10-07 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients inappropriate for metformin therapy
|
US10034877B2
(en)
|
2008-08-06 |
2018-07-31 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients inappropriate for metformin therapy
|
US9486526B2
(en)
|
2008-08-06 |
2016-11-08 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients inappropriate for metformin therapy
|
US8513264B2
(en)
|
2008-09-10 |
2013-08-20 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
US11911388B2
(en)
|
2008-10-16 |
2024-02-27 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
|
US8865729B2
(en)
|
2008-12-23 |
2014-10-21 |
Boehringer Ingelheim International Gmbh |
Salt forms of a xanthine compound
|
US9212183B2
(en)
|
2008-12-23 |
2015-12-15 |
Boehringer Ingelheim International Gmbh |
Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
|
US8846695B2
(en)
|
2009-01-07 |
2014-09-30 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor
|
US9457029B2
(en)
|
2009-11-27 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
|
US10092571B2
(en)
|
2009-11-27 |
2018-10-09 |
Boehringer Ingelheim International Gmbh |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
|
US9603851B2
(en)
|
2010-05-05 |
2017-03-28 |
Boehringer Ingelheim International Gmbh |
Combination therapy
|
US10004747B2
(en)
|
2010-05-05 |
2018-06-26 |
Boehringer Ingelheim International Gmbh |
Combination therapy
|
US9186392B2
(en)
|
2010-05-05 |
2015-11-17 |
Boehringer Ingelheim International Gmbh |
Combination therapy
|
US9149478B2
(en)
|
2010-06-24 |
2015-10-06 |
Boehringer Ingelheim International Gmbh |
Diabetes therapy
|
US11911387B2
(en)
|
2010-11-15 |
2024-02-27 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
US8883800B2
(en)
|
2011-07-15 |
2014-11-11 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
US9199998B2
(en)
|
2011-07-15 |
2015-12-01 |
Boehringer Ingelheim Internatioal Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
US8962636B2
(en)
|
2011-07-15 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
US10195203B2
(en)
|
2012-05-14 |
2019-02-05 |
Boehringr Ingelheim International GmbH |
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
|
US9526730B2
(en)
|
2012-05-14 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
|
US9713618B2
(en)
|
2012-05-24 |
2017-07-25 |
Boehringer Ingelheim International Gmbh |
Method for modifying food intake and regulating food preference with a DPP-4 inhibitor
|
US9526728B2
(en)
|
2014-02-28 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Medical use of a DPP-4 inhibitor
|
US10155000B2
(en)
|
2016-06-10 |
2018-12-18 |
Boehringer Ingelheim International Gmbh |
Medical use of pharmaceutical combination or composition
|